Innovative prenatal testing: Clinical applications and ethical considerations

Mei Chih Huang, Shio Jean Lin, Chih Ling Chen, Tzu Jung Huang

研究成果: Article

摘要

The biomedical technology related to prenatal screen/diagnosis has developed rapidly in recent decades. Many prenatal genetic examinations are now available to assist pregnant women to better understand the status and development of their fetus. Moreover, many commercial advertisements for innovative prenatal examinations are now shown in the media. Cell-free DNA Screening (cfDNA screening), a non-invasive prenatal testing (NIPT) procedure, is a safe and high accuracy test that may be done at an earlier gestational age to screen for fetal aneuploidy. The following questions should be considered when applying cfDNA screening in clinical practice: 1. what is cfDNA screening, 2. who are its potential users, and 3. what ethical and policy considerations are associated with this examination? This article provides relevant information, clinical practice guidelines, and ethical/ policy considerations related to cfDNA screening. Discussing cases involving different clinical situations helps promote understanding of cfDNA screening and maternal-care quality.

原文English
頁(從 - 到)5-10
頁數6
期刊Journal of Nursing
64
發行號5
DOIs
出版狀態Published - 2017 十月 1

指紋

DNA
Biomedical Technology
Quality of Health Care
Aneuploidy
Prenatal Diagnosis
Practice Guidelines
Gestational Age
Pregnant Women
Fetus
Mothers

All Science Journal Classification (ASJC) codes

  • Nursing(all)

引用此文

Huang, Mei Chih ; Lin, Shio Jean ; Chen, Chih Ling ; Huang, Tzu Jung. / Innovative prenatal testing : Clinical applications and ethical considerations. 於: Journal of Nursing. 2017 ; 卷 64, 編號 5. 頁 5-10.
@article{e303cd49fe364549a9157de075425fac,
title = "Innovative prenatal testing: Clinical applications and ethical considerations",
abstract = "The biomedical technology related to prenatal screen/diagnosis has developed rapidly in recent decades. Many prenatal genetic examinations are now available to assist pregnant women to better understand the status and development of their fetus. Moreover, many commercial advertisements for innovative prenatal examinations are now shown in the media. Cell-free DNA Screening (cfDNA screening), a non-invasive prenatal testing (NIPT) procedure, is a safe and high accuracy test that may be done at an earlier gestational age to screen for fetal aneuploidy. The following questions should be considered when applying cfDNA screening in clinical practice: 1. what is cfDNA screening, 2. who are its potential users, and 3. what ethical and policy considerations are associated with this examination? This article provides relevant information, clinical practice guidelines, and ethical/ policy considerations related to cfDNA screening. Discussing cases involving different clinical situations helps promote understanding of cfDNA screening and maternal-care quality.",
author = "Huang, {Mei Chih} and Lin, {Shio Jean} and Chen, {Chih Ling} and Huang, {Tzu Jung}",
year = "2017",
month = "10",
day = "1",
doi = "10.6224/JN.000062",
language = "English",
volume = "64",
pages = "5--10",
journal = "Journal of Nursing",
issn = "0047-262X",
publisher = "Taiwan Nurses Association",
number = "5",

}

Innovative prenatal testing : Clinical applications and ethical considerations. / Huang, Mei Chih; Lin, Shio Jean; Chen, Chih Ling; Huang, Tzu Jung.

於: Journal of Nursing, 卷 64, 編號 5, 01.10.2017, p. 5-10.

研究成果: Article

TY - JOUR

T1 - Innovative prenatal testing

T2 - Clinical applications and ethical considerations

AU - Huang, Mei Chih

AU - Lin, Shio Jean

AU - Chen, Chih Ling

AU - Huang, Tzu Jung

PY - 2017/10/1

Y1 - 2017/10/1

N2 - The biomedical technology related to prenatal screen/diagnosis has developed rapidly in recent decades. Many prenatal genetic examinations are now available to assist pregnant women to better understand the status and development of their fetus. Moreover, many commercial advertisements for innovative prenatal examinations are now shown in the media. Cell-free DNA Screening (cfDNA screening), a non-invasive prenatal testing (NIPT) procedure, is a safe and high accuracy test that may be done at an earlier gestational age to screen for fetal aneuploidy. The following questions should be considered when applying cfDNA screening in clinical practice: 1. what is cfDNA screening, 2. who are its potential users, and 3. what ethical and policy considerations are associated with this examination? This article provides relevant information, clinical practice guidelines, and ethical/ policy considerations related to cfDNA screening. Discussing cases involving different clinical situations helps promote understanding of cfDNA screening and maternal-care quality.

AB - The biomedical technology related to prenatal screen/diagnosis has developed rapidly in recent decades. Many prenatal genetic examinations are now available to assist pregnant women to better understand the status and development of their fetus. Moreover, many commercial advertisements for innovative prenatal examinations are now shown in the media. Cell-free DNA Screening (cfDNA screening), a non-invasive prenatal testing (NIPT) procedure, is a safe and high accuracy test that may be done at an earlier gestational age to screen for fetal aneuploidy. The following questions should be considered when applying cfDNA screening in clinical practice: 1. what is cfDNA screening, 2. who are its potential users, and 3. what ethical and policy considerations are associated with this examination? This article provides relevant information, clinical practice guidelines, and ethical/ policy considerations related to cfDNA screening. Discussing cases involving different clinical situations helps promote understanding of cfDNA screening and maternal-care quality.

UR - http://www.scopus.com/inward/record.url?scp=85030701080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030701080&partnerID=8YFLogxK

U2 - 10.6224/JN.000062

DO - 10.6224/JN.000062

M3 - Article

C2 - 28948585

AN - SCOPUS:85030701080

VL - 64

SP - 5

EP - 10

JO - Journal of Nursing

JF - Journal of Nursing

SN - 0047-262X

IS - 5

ER -